Skip to main content
. 2020 Nov 6;21(21):8338. doi: 10.3390/ijms21218338
LPL Lipoprotein Lipase
Amyloid-Beta
AD Alzheimer’s Disease
ApoC-II ApoproteinC-II
ApoC-III ApoproteinC-III
ChEIs Cholinesterase inhibitors
DMTs Disease-modifying therapeutics
TG Triglycerides
VLDL Very-low-density lipoprotein
CVD Cardiovascular Disease
CNS Central Nervous system
OPCs Oligodendrocytes
GPIHBP Glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1
TRL Triglyceride-rich lipoproteins
LMF1 Lipoprotein Maturation factor 1
FFAs Free Fatty Acids
LRP LDL receptor-related protein/α2-macroglobulin receptor LRP2
RAP Receptor associated protein
HSPGs Heparan sulfate proteoglycans
ANGPTL (3,4,8) Angiopoietin-like protein (3,4,8)
HDL High-density lipoproteins
DOCK Dedicator of cytokinesis
APOE Apoprotein E
CLU Clusterin
ApoJ Apoprotein J
TREM2 Triggering receptor expressed on myeloid cells
PUFAs Polyunsaturated fatty acids
SORLA Sortilin
MS Multiple Sclerosis
DAMS Disease Associated Microglia
PAMS Proliferative-region-associated-microglia
FCS Familial chylomicronemia syndrome
LOAD Late onset AD
CAD Coronary Artery Disease
SAD Sporadic AD